About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Oxymorphone Patch Program Update
May 14, 2015
Click here to read more
Post navigation
Previous Post
Chairman Resignation
Next Post
Apppointment of Consultant to Assist in Commercialising TPM for the Mass Market
Related Posts
Phosphagenics Expands License Agreement for Diclofenac Gel
May 18, 2016
2016 July 29 CEO Quarterly Update
July 29, 2016
Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete
December 12, 2016